0 false false false false false false false false false false true false false false false false false No description of principal activity 2024-03-01 Sage Accounts Production Advanced 2023 - FRS102_2023 xbrli:pure xbrli:shares iso4217:GBP 08762919 2024-03-01 2025-02-28 08762919 2025-02-28 08762919 2024-02-29 08762919 2023-03-01 2024-02-29 08762919 2024-02-29 08762919 2023-02-28 08762919 bus:Director2 2024-03-01 2025-02-28 08762919 core:ShareCapital 2025-02-28 08762919 core:ShareCapital 2024-02-29 08762919 core:RetainedEarningsAccumulatedLosses 2025-02-28 08762919 core:RetainedEarningsAccumulatedLosses 2024-02-29 08762919 bus:SmallEntities 2024-03-01 2025-02-28 08762919 bus:AuditExemptWithAccountantsReport 2024-03-01 2025-02-28 08762919 bus:SmallCompaniesRegimeForAccounts 2024-03-01 2025-02-28 08762919 bus:PrivateLimitedCompanyLtd 2024-03-01 2025-02-28 08762919 bus:FullAccounts 2024-03-01 2025-02-28
COMPANY REGISTRATION NUMBER: 08762919

SKIN ASSOCIATES (MEDICAL) LIMITED

FILLETED UNAUDITED FINANCIAL STATEMENTS

28 February 2025

SKIN ASSOCIATES (MEDICAL) LIMITED

STATEMENT OF FINANCIAL POSITION

28 February 2025

| 2025 | 2024
Note | £ | £

Current assets

Debtors | 4 | 45,061 | 56,061
| --------- | ---------
Net current assets | 45,061 | 56,061
| --------- | ---------
Total assets less current liabilities | 45,061 | 56,061
| --------- | ---------

Capital and reserves

Called up share capital | 100 | 100
Profit and loss account | 44,961 | 55,961
| --------- | ---------
Shareholders funds | 45,061 | 56,061
| --------- | ---------

These financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies' regime and in accordance with Section 1A of FRS 102 'The Financial Reporting Standard applicable in the UK and Republic of Ireland'.
In accordance with section 444 of the Companies Act 2006, the statement of income and retained earnings has not been delivered.
For the year ending 28 February 2025 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.
Directors' responsibilities:
- The members have not required the company to obtain an audit of its financial statements for the year in question in accordance with section 476 ;
- The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of financial statements .
These financial statements were approved by the board of directors and authorised for issue on 8 August 2025 , and are signed on behalf of the board by:

Mrs F C Dilazzaro
Director

Company registration number: 08762919

SKIN ASSOCIATES (MEDICAL) LIMITED

NOTES TO THE FINANCIAL STATEMENTS

YEAR ENDED 28 FEBRUARY 2025
1. General information
The company is a private company limited by shares, registered in England and Wales. The address of the registered office is 168 Church Road, Hove, East Sussex, BN3 2DL, United Kingdom.
2. Statement of compliance
These financial statements have been prepared in compliance with Section 1A of FRS 102, 'The Financial Reporting Standard applicable in the UK and the Republic of Ireland'.
3. Accounting policies
Basis of preparation
The financial statements have been prepared on the historical cost basis, as modified by the revaluation of certain financial assets and liabilities and investment properties measured at fair value through profit or loss.
The financial statements are prepared in sterling, which is the functional currency of the entity.
Going concern
The company was dormant in the year.
Judgements and key sources of estimation uncertainty
The preparation of the financial statements requires management to make judgements, estimates and assumptions that affect the amounts reported. These estimates and judgements are continually reviewed and are based on experience and other factors, including expectations of future events that are believed to be reasonable under the circumstances.
Financial instruments
Financial instruments are classified and accounted for, according to the substance of the contractual arrangement, as either financial assets, financial liabilities or equity instruments. An equity instrument is any contract that evidences a residual interest in the assets of the company after deducting all of its liabilities.
4. Debtors

| 2025 | 2024
| £ | £
Amounts owed by group undertakings and undertakings in which the company has a participating interest | 45,061 | 56,061
| --------- | ---------

5. Related party transactions
The company was under the control of Skin Associates (Holdings) Limited throughout the current period. As at 28th February 2025 the company was owed £124,561 (2024 £124,561) by Skin Associates Limited. Skin Associates Mr F Dilazzaro and Mrs F Dilazzaro are shareholders and directors of Skin Associates Limited. As at 28th February 2025 the company owed £79,500 (2024 £68,500) to Skin Associates (Holdings) Limited. Mr F Dilazzaro and Mrs F Dilazzaro are shareholders and directors of Skin Associates (Holdings) Limited.